News

A new cancer vaccine, comprised of human antibodies fused with tumor-specific protein, is ready to begin human testing.

Teknova has announced the appointment of Stephen Gunstream as chief executive officer.

A study from the National Institutes of Health confirms that neurofilament light chain as a blood biomarker can detect brain injury and predict recovery in multiple groups, including professional hockey players with acute or chronic concussions and clinic-based patients with mild, moderate, or severe traumatic brain injury.

A new study sheds light on how extracellular vesicles, which are released by tumor cells into the bloodstream, promote the spread of cancer.

The presence of an abnormal number of chromosomes in the genetic profile of early-stage embryos may be far more common - and potentially less threatening - during normal human development than is currently appreciated, according to new research from Johns Hopkins University biologists.

Researchers have discovered that breast cancer cells can alter the function of immune cells known as Natural killer cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Massive blocks of genes—inherited together ‘plug and play’ style—may play a larger role in evolutionary adaption than previously thought, according to new research.

An engineered bacterial toxin is a key part of a newly developed gene editor that can make single-base changes in human mitochondrial DNA.

In experiments in rats and mice, scientists report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.

Scientists have developed a new approach to immunological tumor treatment. Their method is based on the specific blockade of an immune checkpoint by a stable "mirror-image" peptide.